Abstract

Modern reconstructive orthopedic surgery would be unthinkable without the availability of alloplastic total joint prostheses. In the 1960s, faced with the problem that resection arthroplasty as an uncertain procedure with recurrent deformity and limited motion as common complications, Sir John Charnley developed a successful low-friction total alloplastic joint reconstruction arthroplasty device.1 Since that time, with the evolution of surgical techniques, implant materials, and designs, excellent long-term function and quality of life improvement results have been reported along with device survival rates exceeding 90% after 10 years in younger patients.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.